CEPR researches how US government-granted monopolies of patents, copyrights, and other forms of intellectual property redistribute income upward and the role of digital global trade and international commercial agreements on inequality and economic mobility.
CEPR investiga cómo los monopolios de patentes, derechos de autor y otras formas de propiedad intelectual otorgados por el gobierno de los Estados Unidos redistribuyen el ingreso hacia arriba. CEPR analiza el papel del comercio mundial digital y los acuerdos comerciales internacionales sobre desigualdad y movilidad económica.
CEPR researches how US government-granted monopolies of patents, copyrights, and other forms of intellectual property redistribute income upward and the role of digital global trade and international commercial agreements on inequality and economic mobility.
CEPR investiga cómo los monopolios de patentes, derechos de autor y otras formas de propiedad intelectual otorgados por el gobierno de los Estados Unidos redistribuyen el ingreso hacia arriba. CEPR analiza el papel del comercio mundial digital y los acuerdos comerciales internacionales sobre desigualdad y movilidad económica.
· Op-Ed/Commentary
GovernmentIntellectual PropertyUS Warren–Schakowsky Bill Is a Huge Step Toward Bringing Drug Costs DownDean Baker / December 24, 2018
· Op-Ed/Commentary
Health and Social ProgramsIntellectual Property NYT Does Some Mind Reading of Republican Members of Congress on Drug Pricing PolicyCEPR / October 20, 2018
· report
InequalityIntellectual PropertyUS Working Paper: Is Intellectual Property the Root of All Evil? Patents, Copyrights, and InequalityDean Baker / October 02, 2018
· Op-Ed/Commentary
Globalization and TradeIntellectual PropertyUS Where Donald Trump and the Elites Agree on Protectionism: Patents and CopyrightsDean Baker / July 30, 2018
· Op-Ed/Commentary
Intellectual PropertyUSWorkers Response to "Janus": Take Their Intellectual "Property"Dean Baker / July 02, 2018
· Op-Ed/Commentary
Intellectual PropertyUS From Trade War to Class War: Screw Pfizer’s Drug PatentsDean Baker / June 11, 2018
· Op-Ed/Commentary
Intellectual PropertyUS Patents Without Examination: A Bad Solution For The 21st CenturyDean Baker / April 30, 2018
· Op-Ed/Commentary
Globalization and TradeIntellectual PropertyUS Why Should the Poor Pay High Drug Prices?Dean Baker / April 02, 2018
· Op-Ed/Commentary
Intellectual PropertyUS How Would You Donate $450 Million?Dean Baker / November 21, 2017
· Op-Ed/Commentary
Globalization and TradeIntellectual PropertyUSWorld Intellectual Property for the Twenty-First-Century EconomyDean Baker / October 17, 2017
